Concepedia

Publication | Closed Access

A randomized, phase 2 clinical trial of lithium carbonate in Machado‐Joseph disease

72

Citations

25

References

2014

Year

Abstract

Lithium was safe and well tolerated, but it had no effect on progression when measured using the NESSCA in patients with MJD/SCA3. This slowdown in secondary outcomes deserves further clarification.

References

YearCitations

Page 1